RDA2
A
2
197122
131840
1026
1
262153
12
dat.hart1999
787
12
13
6
1
2
3
4
5
6
16
6
262153
6
AFASAK
262153
4
SPAF
262153
6
BAATAF
262153
4
CAFA
262153
6
SPINAF
262153
4
EAFT
13
6
1989
1991
1990
1991
1992
1993
13
6
9
8
3
6
7
20
13
6
335
210
212
187
281
225
13
6
413
263
487
237
489
507
13
6
19
19
13
9
23
50
13
6
336
211
208
191
290
214
13
6
398
245
435
241
483
405
16
6
262153
7
placebo
262153
7
placebo
262153
7
control
262153
7
placebo
262153
7
placebo
262153
7
placebo
16
6
262153
7
primary
262153
7
primary
262153
7
primary
262153
7
primary
262153
7
primary
262153
9
secondary
16
6
262153
7
2.8-4.2
262153
7
2.0-4.5
262153
7
1.5-2.7
262153
7
2.0-3.0
262153
7
1.4-2.8
262153
7
2.5-4.0
1026
1
262153
5
names
16
12
262153
5
trial
262153
5
study
262153
4
year
262153
3
x1i
262153
3
n1i
262153
3
t1i
262153
3
x2i
262153
3
n2i
262153
3
t2i
262153
7
compgrp
262153
8
prevtype
262153
5
trinr
1026
1
262153
5
class
16
1
262153
10
data.frame
1026
1
262153
9
row.names
13
2
NA
-6
254
254
